Doximity, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD 240.76 M

Doximity, Inc. EBITDA is USD 240.76 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 32.23% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Doximity, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 182.08 M, a 34.48% change year over year.
  • Doximity, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 135.39 M, a 14.18% change year over year.
  • Doximity, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 118.58 M, a 108.01% change year over year.
  • Doximity, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 57.01 M.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)